LabVantage announced today that it is purchasing Applied Bio's SQL*LIMS business. While he couldn't comment at length yet, LabVantage VP of Corporate Development Ron Kasner offered a few thoughts via email:
PharmaQbd: What is the plan for integrating SAPPHIRE and SQL*LIMS? How quickly will this happen?
R.K.: Until the closing date, both companies will operate in a business-as-usual mode. More information about the integration plan, including product integration will be available post closing.
PharmaQbD: What will SAPPHIRE customers likely to get that they didn't have before, from a technology standpoint? What will SQL*LIMS customers get?
R.K.: All of our customers will gain access to a broader portfolio of software products and services, with our ongoing commitment to world-class customer service. We will continue to execute against our strategic product direction for SAPPHIRE. Our intent is to expand functionality within SAPPHIRE™ by leveraging the SQL*LIMS team’s domain knowledge and the robust product functionality within SQL*LIMS. At the same time, we will maintain our commitment to support the SQL*LIMS product and customers.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment